Literature DB >> 20809068

Risk factors for cerebrovascular and cardiovascular diseases beyond age 75 years.

N Mostafaie1, K R Huber, C Sebesta, W Krampla, S Jungwirth, S Zehetmayer, M Hinterberger, W Krugluger, K H Tragl, P Fischer.   

Abstract

Globally, cardiovascular diseases (CVDs) are the number one cause of all mortalities. Of these deaths, 7.6 million are due to heart attacks, and 5.7 millions are due to stroke. The Vienna Transdanube Aging Study (VITA), a population-based cohort study, enabled us to evaluate associations between the known major risk factors for cerebrovascular and CVDs and their appearance beyond age 75 years. Using a single birth cohort, age was excluded as confounding factor. In the baseline investigations in the Danube Hospital, 606 individuals took part and were examined completely at baseline. After 60 months, 508 patients were re-examined. Each participant underwent an indepth investigation with the duration of 7 h, including neuropsychological testing, as well as analyses of biochemical, clinical chemical and genetic parameters, and magnetic resonance imaging (MRI) of the brain. In the present study, only a history of cerebral and cardiovascular events at the baseline or smoking was associated significantly with the appearance of CVDs. In a multiple model both risk factors-history of cerebral and cardiovascular events at the baseline (p = 0.0003, OR 2.36, 95% CI 1.49-3.76) and smoking (p = 0.0005, OR 1.57, 95% CI 1.22-2.03)-remained significant. However, the predictive value of this assessment model was low. The rescaled r² of the model was 0.088. A significant correlation was found only between exposure to cigarette smoke or a history of previous CVDs, such as stroke or myocardial infarction. Smoking or earlier CVDs greatly increase the risk for further cerebral and cardiovascular events in persons after 75 years.

Entities:  

Mesh:

Year:  2010        PMID: 20809068     DOI: 10.1007/s00702-010-0466-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

Review 1.  A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells.

Authors:  C E Hack; G J Wolbink; C Schalkwijk; H Speijer; W T Hermens; H van den Bosch
Journal:  Immunol Today       Date:  1997-03

2.  Cigarette smoking as a risk factor for stroke. The Framingham Study.

Authors:  P A Wolf; R B D'Agostino; W B Kannel; R Bonita; A J Belanger
Journal:  JAMA       Date:  1988-02-19       Impact factor: 56.272

3.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Conversion from subtypes of mild cognitive impairment to Alzheimer dementia.

Authors:  P Fischer; S Jungwirth; S Zehetmayer; S Weissgram; S Hoenigschnabl; E Gelpi; W Krampla; K H Tragl
Journal:  Neurology       Date:  2007-01-23       Impact factor: 9.910

6.  Active and passive smoking are associated with increased carotid wall thickness. The Atherosclerosis Risk in Communities Study.

Authors:  G Howard; G L Burke; M Szklo; G S Tell; J Eckfeldt; G Evans; G Heiss
Journal:  Arch Intern Med       Date:  1994-06-13

7.  Relation of smoking with carotid artery wall thickness and stenosis in older adults. The Cardiovascular Health Study. The Cardiovascular Health Study (CHS) Collaborative Research Group.

Authors:  G S Tell; J F Polak; B J Ward; S J Kittner; P J Savage; J Robbins
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

8.  Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.

Authors:  Anne B Rossebø; Terje R Pedersen; Christopher Allen; Kurt Boman; John Chambers; Kenneth Egstrup; Eva Gerdts; Christa Gohlke-Bärwolf; Ingar Holme; V Antero Y Kesäniemi; William Malbecq; Christoph Nienaber; Simon Ray; Terje Skjaerpe; Kristian Wachtell; Ronnie Willenheimer
Journal:  Am J Cardiol       Date:  2007-02-15       Impact factor: 2.778

9.  Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Authors:  John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel L Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico P Veltri; A David Marais; Eric de Groot
Journal:  N Engl J Med       Date:  2008-03-30       Impact factor: 91.245

10.  Cigarette smoking accelerates carotid artery intimal hyperplasia in a dose-dependent manner.

Authors:  P V Petrik; H A Gelabert; W S Moore; W Quinones-Baldrich; M M Law
Journal:  Stroke       Date:  1995-08       Impact factor: 7.914

View more
  1 in total

1.  Associations between T1 white matter lesion volume and regional white matter microstructure in aging.

Authors:  Elizabeth C Leritz; Juli Shepel; Victoria J Williams; Lewis A Lipsitz; Regina E McGlinchey; William P Milberg; David H Salat
Journal:  Hum Brain Mapp       Date:  2013-01-30       Impact factor: 5.038

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.